Recent Finacing
Recent Raise
Scout Bio develops one-time AAV gene therapies for chronic pet diseases, delivering intramuscular vectors to induce long-term therapeutic protein expression for conditions like CKD-associated anemia, pain, and diabetes.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Scout Bio.
